logo
  • 首页
  • 学术期刊
  • 论文检测
  • AIGC检测
  • 热点
  • 更多
    • 数据

ADR updates from Canada

被引:0
|
作者:
机构:
来源:
Reactions Weekly | 1998年 / 712卷 / 1期
关键词:
Olanzapine; Saquinavir; Latanoprost; Cefaclor; Erythema Multiforme;
D O I:
10.2165/00128415-199807120-00004
中图分类号:
学科分类号:
摘要:
引用
收藏
页码:3 / 3
相关论文
共 50 条
  • [31] ADR update from Health Canada
    Reactions Weekly, 2003, 972 (1) : 2 - 2
  • [32] ADR update from Health Canada
    Reactions Weekly, 2003, 947-948 (1) : 2 - 2
  • [33] Denosumab: ONJ and hypocalcaemia ADR updates in EU
    Reactions Weekly, 2014, 1519 (1) : 1 - 1
  • [34] ADR reporting is inadequate in Canada
    Reactions Weekly, 2001, 851 (1) : 4 - 4
  • [35] ADR reports up 11.2% in Canada
    Reactions Weekly, 2005, 1047 (1) : 3 - 3
  • [36] Canada launches online ADR database
    Reactions Weekly, 2005, 1054 (1) : 2 - 2
  • [37] Bisphosphonate labelling updates in Canada
    Reactions Weekly, 2012, 1384 (1) : 2 - 2
  • [38] Cross-Canada updates
    不详
    论文数: 0 引用数: 0 h-index: 0
    不详
    CANADIAN PHARMACISTS JOURNAL, 2021, 154 (01) : 16 - 18
  • [39] Cross-Canada updates
    不详
    论文数: 0 引用数: 0 h-index: 0
    不详
    CANADIAN PHARMACISTS JOURNAL, 2018, 151 (02) : 91 - 93
  • [40] GSK updates Avandia label for Canada
    Reactions Weekly, 2007, 1155 (1) : 5 - 5
← 12345 →